Skip to content

An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study

An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study: A Stage 1 Trial for SADV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07140276
Enrollment
63
Registered
2025-08-24
Start date
2007-07-03
Completion date
2010-06-30
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Abuse, Domestic Violence

Brief summary

Investigators will conduct a randomized trial comparing individual SADV to a manualized comparison condition that focuses on substance use only.

Detailed description

The randomized trial will be informed by previous work developing and refining the interventions and training materials used in the randomized trial. The focus of this registration is the randomized trial.

Interventions

12 weeks individual psychotherapy

BEHAVIORALIndividual Drug Counseling manual

12 weeks using the manual provided

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Men referred by the courts or probation for treatment of substance use who have domestic violence related problems.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* referred by the courts or probation for treatment of substance use and domestic violence and who * meet current DSM-IV criteria for substance dependence (alcohol, cocaine and marijuana, and who have used that substance within the 30 days prior to the screening session) * report physical violence in an intimate relationship (pushing, slapping, kicking) within 30 days prior to screening * can read English at a 6th grade level.

Exclusion criteria

* Currently in withdrawal from substances and in need of detoxification (such individuals may be re-evaluated following detoxification) * Have cognitive impairment (a mini mental state score \<25) * Have psychomotor epilepsy (e.g. impulsivity or rage related symptoms secondary to a seizure disorder, as this medical diagnosis is likely to be a confound in the proposed study) * Have major medical complications such as a head injury/trauma, or HIV dementia that may also be a confound in the study interventions * Currently receiving either substance abuse or IPV treatment elsewhere * Have a lifetime history of any psychotic or bipolar disorder * Currently suicidal or homicidal.

Design outcomes

Primary

MeasureTime frameDescription
Mean Days of substance useWeekly up to 12 weeksDays of substance use weekly from each participant endorsed as Y/N, by Self-report using time line follow back method, verified by alcohol concentration and urine toxicology
Mean Days of physical violence useWeekly up to 12 weeksDays of physical violence use weekly from each participant endorsed as Y/N, by Self-report using time line follow back method, verified by female collateral informant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026